Galderma marks the 25th anniversary of Sculptra® with new data and recent approvals, strengthening its leadership in regenerative aesthetics. Sculptra has been used to enhance skin rejuvenation, thanks to its unique formulation of poly-L-lactic acid (PLLA-SCA™).
It has helped millions of people worldwide restore their skin’s natural radiance by working in harmony with the body’s own processes. As one of the first treatments to focus on regenerative skin care, Sculptra has become a key solution for those looking to restore volume and improve skin quality.
Its ability to rejuvenate from within by stimulating the body’s natural collagen production has made it an important treatment in modern aesthetics.
Expansion to China and global reach
Recently, Sculptra received approval in China, one of the world’s fastest-growing markets for aesthetic treatments. This development expands its reach, making it available in over 40 countries worldwide and increasing access for patients looking for effective skin rejuvenation.
Over the years, Sculptra has maintained its reputation for helping people achieve youthful, glowing skin. As it continues to evolve and expand, it remains a significant player in the field of regenerative aesthetics, shaping the future of skincare solutions globally.
Advancing science with new data
At the 2024 American Society for Dermatologic Surgery (ASDS) Annual Meeting, new research showcased the regenerative strength of Sculptra. A study comparing Sculptra with other biostimulators found that it activates 16 pathways related to tissue remodelling and collagen formation, outperforming its competitors.
These findings, along with its anti-inflammatory effects, help explain why Sculptra is so effective in improving skin quality and restoring facial fat structure. Also, it plays a key role in reducing visible signs of ageing.
Moreover, studies published in the Journal of Drugs in Dermatology further supported Sculptra’s benefits. Results revealed significant improvement in moderate to severe cheek wrinkles, with effects lasting over a year.
More than 84% of patients reported natural-looking results and expressed interest in undergoing repeat treatments.
Leading the way in regenerative aesthetics
Regenerative aesthetics is changing the skincare industry by focusing on rejuvenating the skin from within. Sculptra’s unique PLLA-SCA™ formula works by stimulating the production of collagen, elastin, and other key components in the skin.
This helps improve skin texture and also targets deeper issues like volume loss and skin sagging.
Sculptra’s evolution reflects Galderma’s dedication to addressing diverse patient concerns. From treating AIDS-related facial wasting to enhancing skin firmness and radiance, Sculptra sets industry benchmarks with its evolution.
Its ability to tackle challenges like facial alterations due to rapid weight loss exemplifies its versatility and impact.
A legacy of radiance
Galderma’s Sculptra’s 25-year journey shows how it has changed the world of skin care. By boosting the body’s natural collagen, it helps rejuvenate the skin, restore lost volume, and reduce signs of ageing.
As Sculptra expands globally and evolves with new research, it continues to lead and shape the future of skincare.
Reference link: https://www.galderma.com/news/celebrating-25-years-sculptrar-new-data-and-recent-approval-china-cements-galdermas-leadership